Halozyme Stops MSD Sales Of Cancer Jab In Parts Of Europe
Halozyme has persuaded a Dutch court to stop Merck Sharp & Dohme from selling an injectable version of the cancer treatment Keytruda in parts of Europe, proving that the product infringes...To view the full article, register now.
Already a subscriber? Click here to view full article